GLP-1 Prescriptions and Liability Risks With new indications for GLP-1 medications in areas such as sleep apnea, substance use disorder, and chronic kidney disease, the demand for semaglutide-based treatments is expected to continue rising
These hormones regulate blood sugar, slow gastric emptying, reduce appetite, and influence how the body stores and burns fat
Our experts will assess your needs, answer your questions, and personalise your treatment plan
Across the regulatory and litigation landscape, we can expect both even more material monetary fines, reputational damage, and additional regulatory impacts through enforcement orders, as weve seen in the financial services sector
So, I dont think any of thats necessary